|
Avid Radiopharmaceuticals |
|
|
3711 Market Street, 7th floor
Philadelphia, PA 19104 USA
phone:215-298-0700
fax:413-826-0416
|
|
| Symbol |
Private |
| Founded |
0 |
| Employees |
|
|
|
| www.avidrp.com
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Radiopharmaceuticals for imaging Alzheimer's disease pathology. |
|
| Management |
| Daniel M. Skovronsky, M.D., Ph.D., Founder and CEO; Alan P. Carpenter, Jr., Ph.D., J.D., Vice President, Business Development, Legal & Regulatory Affairs; Franz F. Hefti, Ph.D., Chief Scientific Officer; Michael J. Pontecorvo, Ph.D., Vice President, Clinical Development; Paul Kennedy, Ph.D., Vice President, VP Manufacturing |
| |
|
|
| |
|
| Keywords |
| hypothesis, tomography, radiolabeled, plaques, amyloid |
|
|
|
| Description |
|
Avid Radiopharmaceuticals, Inc. is a product-focused molecular imaging company that is a pioneer in developing radiopharmaceuticals for imaging Alzheimer's disease pathology. |
|
| Products / Services |
Two of Avid's radiopharmaceuticals are already in clinical trials, and Avid intends to make these products available to pharmaceutical companies that are seeking to develop new drugs for treatment of Alzheimer's disease. By providing a readily measured biomarker for this disease, Avid's products can facilitate testing of therapies aimed at amyloid plaques. Avid's first commercial product for the Alzheimer's diagnostic market is ready for development and will be used for positron emission tomography (PET).
|
|
| Technology / Differentiation |
| Avid's Alzheimer's disease program is based on the hypothesis that in vivo detection of amyloid plaques by positron emission computed tomography (PET) or single photon emission computed tomography (SPECT) imaging would provide useful biomarkers for monitoring and diagnosis of Alzheimer's disease. To test this hypothesis, we have developed novel radiolabeled compounds that specifically and sensitively bind A b (the chief constituent of amyloid plaques), and are testing these compounds as molecular imaging agents in preclinical and clinical trials. |
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members